
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
Fibronectin Active Fragment Control
CAS:Fibronectin: a ~440kDa glycoprotein, binds integrins, collagen, fibrin, and heparan sulfate in the extracellular matrix.Formula:C18H32N8O9Purity:98%Color and Shape:SolidMolecular weight:504.49HIF-1 α (556-574)
HIF-1 alpha (556-574) is derived from hypoxia-inducible factor 1-alpha (HIF-1 alpha), a subunit of the heterodimeric transcription factor HIF-1 and is responsible for maintaining oxygen homeostasis. HIF-1 alpha is expressed under hypoxic conditions and is oxygen sensitive. Hypoxia can occur in cancer, heart disease and pulmonary disorders.Structurally HIF-1 alpha contains a N-terminal transactivation domain (N-TAD) which stabilises HIF-1 alpha and a C-terminal transactivation domain (C-TAD) which under hypoxic conditions regulates the transcription of HIF-1 alpha. Moreover HIF-1 alpha features an oxygen dependent degradation domain containing two proline residues and a lysine532. The two proline residues are substrates of prolyl-4-hydroxylases (PHDs) which in the presence of sufficient oxygen, are hydroxylated. Similarly the lysine residue is acetylated by arrest-defective-1 and this is reduced in hypoxic conditions. These hydroxylated prolines and acetylated lysine target HIF-1 alpha for ubiquitination and degradation.Purity:Min. 95%Color and Shape:PowderMolecular weight:2,253 g/molH-2Dk polyomavirus MT peptide RRLGRTLLL
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolSHROOM2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SHROOM2 antibody, catalog no. 70R-5079Purity:Min. 95%H-RLVDDFLLV-OH
Peptide H-RLVDDFLLV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLVDDFLLV-OH include the following: Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region L Wooldridge , A Lissina, J Vernazza - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636765 Artificial Antigen-Presenting Cells Transduced with Telomerase Efficiently Expand Epitope-Specific, Human Leukocyte Antigen-Restricted Cytotoxic T Cells J Dupont, JB Latouche, C Ma, M Sadelain - Cancer research, 2005 - AACRhttps://aacrjournals.org/cancerres/article-abstract/65/12/5417/518137 Vaccines as consolidation therapy for myeloid leukemia G Alatrash , JJ Molldrem - Expert review of hematology, 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/ehm.10.80 Tumor-associated antigens G Alatrash , AK Crain, JJ Molldrem - Immune biology of allogeneic , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128126301000074 Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs). C Ragone, C Manolio, B Cavalluzzo - for ImmunoTherapy of , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166618/ Telomerase based anticancer immunotherapy and vaccines approaches C Kailashiya, HB Sharma , J Kailashiya - Vaccine, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X17312276 Cytotoxic T cell immunity against telomerase reverse transcriptase in humans B Minev, J Hipp, H Firat, JD Schmidt - Proceedings of the , 2000 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.070560797 Recent patents on anti-telomerase cancer therapy A Agrawal , S Dang , R Gabrani - Recent patents on anti-cancer , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/pra/2012/00000007/00000001/art00008NEDD9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NEDD9 antibody, catalog no. 70R-6076Purity:Min. 95%H-GNDVAFHFNPR-OH
Peptide H-GNDVAFHFNPR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GNDVAFHFNPR-OH include the following: Assessment of Wound Bed Delivery of Galectin-3 to Modulate Macrophage Polarization, Re-epithelialization and Collagen Synthesis in a Murine Model of Excisional KM McLeod, MD Gregerio, D Tinney, JJW Carmichael- 2024 - preprints.orghttps://www.preprints.org/manuscript/202408.1653H-RIK-OH
Peptide H-RIK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RIK-OH include the following: A serine kinase associates with the RAL GTPase and phosphorylates RAL-interacting protein 1 O Jilkina, RP Bhullar - Biochimica et Biophysica Acta (BBA)-Molecular Cell , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0167488906001613 Development of peptide-based sirtuin defatty-acylase inhibitors identified by the fluorescence probe, SFP3, that can efficiently measure defatty-acylase activity of M Kawaguchi, N Ieda , H Nakagawa - Journal of Medicinal , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b00315 Suppressive effect of an analog of the antimicrobial peptide of LL"â37 on colon cancer cells via exosome"âencapsulated miRNAs M Hayashi, K Kuroda, K Ihara - journal of molecular , 2018 - spandidos-publications.comhttps://www.spandidos-publications.com/ijmm/42/6/3009 Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2 J Morimoto , Y Hayashi , H Suga - Angewandte Chemie, 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ange.201108118 Atrial natriuretic peptide secretion following subarachnoid hemorrhage in spontaneously hypertensive rats J Josko , S Hendryk - Journal of physiology , 1996 - yadda.icm.edu.plhttps://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-ee69c3ce-c68e-49a7-940e-f059ca3b0a63/c/641-648.pdf Molecular tools for the construction of peptide-based materials BEI Ramakers, JCM Van Hest , D Löwik - Chemical Society Reviews, 2014 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2014/cs/c3cs60362hLaminin (925-933)
CAS:Laminin 925-933 is a peptide originating from residues 925-933 of the laminin B1 chain, known for its binding affinity to the laminin receptor.Formula:C40H62N12O14SPurity:98%Color and Shape:SolidMolecular weight:967.06H-SLYNTVAVL-OH
Peptide H-SLYNTVAVL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLYNTVAVL-OH include the following: Newly exerted t cell pressures on mutated epitopes following transmission help maintain consensus HIV-1 sequences EM Eriksson, T Liegler, CE Keh, AC Karlsson - Plos one, 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120787 Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope DK Cole , A Fuller, G Dolton , E Zervoudi - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2017.01503/full Large-scale computational identification of HIV T-cell epitopes C Schönbach , Y Kun, V Brusic - Immunology and cell biology, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1440-1711.2002.01089.x HIV molecular immunology database BTM Korber - 1999 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=xTumBANMHfoC&oi=fnd&pg=PR3&dq=(%22H-SLYNTVAVL-OH%22+OR+%22NH2-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Val-Leu-OH%22+OR+%22SLYNTVAVL%22)+AND+peptide&ots=sUb3QDCs2L&sig=Ebn_em_tsPIFkbgg91OJmVrQZqw HIV molecular immunology database BTM Korber - 1999 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=xTumBANMHfoC&oi=fnd&pg=PR3&dq=(%22H-SLYNTVAVL-OH%22+OR+%22NH2-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Val-Leu-OH%22+OR+%22SLYNTVAVL%22)+AND+peptide&ots=sUb3QDCs6F&sig=3meV8qeBnL23wVSQzZJfbsqlsxI HIV molecular immunology database BTM Korber - 1998 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=iZDcsfAbyE8C&oi=fnd&pg=PR3&dq=(%22H-SLYNTVAVL-OH%22+OR+%22NH2-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Val-Leu-OH%22+OR+%22SLYNTVAVL%22)+AND+peptide&ots=XP4Z7rNmHY&sig=Bk3VKg9uRhg6LlMwivOIJN6io2I HIV molecular immunology database BTM Korber - 1998 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=iZDcsfAbyE8C&oi=fnd&pg=PR3&dq=(%22H-SLYNTVAVL-OH%22+OR+%22NH2-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Val-Leu-OH%22+OR+%22SLYNTVAVL%22)+AND+peptide&ots=XP4Z7rNmLS&sig=Am2n81W8T1ihW1FlF2mHERVtHK4 Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope AKN Iversen, G Stewart-Jones, GH Learn - Nature , 2006 - nature.comhttps://www.nature.com/articles/ni1298N-(tert-Butoxycarbonyl)-L-aspartic Acid
CAS:Formula:C9H15NO6Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:233.22C3ORF19 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C3orf19 antibody, catalog no. 70R-4349Purity:Min. 95%3-(2-Acetamidophenyl)acrylic acid
CAS:Formula:C11H11NO3Purity:98%Color and Shape:SolidMolecular weight:205.2099α-Helical CRF (12-41)
Catalogue peptide; min. 95% purityFormula:C152H251N43O47S2Molecular weight:3,497 g/molUrumin
CAS:Urumin, a compound with antiviral properties, inhibits human influenza A virus growth, particularly the PR8 strain, with an inhibitory concentration (IC 50) ofFormula:C129H198N42O35S2Purity:98%Color and Shape:SolidMolecular weight:2961.34ADORA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADORA1 antibody, catalog no. 70R-9942Purity:Min. 95%L17E
CAS:L17E is an endosomolytic peptide derived from the cationic and membrane-lytic spider venom peptide M-lycotoxin and contains a substitution of leucine by glutamic acid at position 17. L17E is able to promote the endocytic uptake and cytosolic delivery of exosome-encapsulated proteins.A major obstacles to intracellular targeting by antibodies is the limited release of the antibodies into the cytosol, once inside endosomes. L17E can achieve an enhanced cellular uptake via the induction of micropinocytosis. Once inside the endosome, positively charged L17E is able to preferentially disrupt negatively charged endosomal membranes to enable a marked cytosolic liberation of antibodies (immunoglobulins G (IgGs)) from endosomes.L17E had little pH dependence and no enhanced helical structure is needed for L17E-mediated membrane lysis.Formula:C134H219N37O32Color and Shape:PowderMolecular weight:2,857.7 g/molH-ENQLEVLEVSWLHGLK-OH
Peptide H-ENQLEVLEVSWLHGLK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ENQLEVLEVSWLHGLK-OH include the following: Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of P Majek , Z Sovova, K Pecankova, J Cermak - Cancer , 2022 - content.iospress.comhttps://content.iospress.com/articles/cancer-biomarkers/cbm210033 Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2 P Majek , Z Riedelova-Reicheltova, J Suttnar - Disease , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2014/178709 Research Article Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2 P Majek , Z Riedelova-Reicheltova, J Suttnar - academia.eduhttps://www.academia.edu/download/43135240/178709.pdf Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome P Majek , Z Reicheltova, J Suttnar, J ÃÅermak, JE Dyr - Proteome Science, 2012 - Springerhttps://link.springer.com/article/10.1186/1477-5956-10-31 A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth J Boateng , R Kay , L Lancashire - PROTEOMICS , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.200800190 Protein Significance Analysis of Multiple Reaction Monitoring (MRM) Data via Generalized Linear Mixed Effect Models ì âì¢âŠÃ¬ËË - 2016 - s-space.snu.ac.krhttps://s-space.snu.ac.kr/handle/10371/131307 Specific isoforms of leucine-rich alpha2-glycoprotein detected in the proliferative endometrium of women undergoing assisted reproduction are associated with DJ Gillott, HM Al-Rumaih, KY Leung, A Eldib - Fertility and sterility, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0015028207002178Angiotensin IV (Human)
CAS:Angiotensin IV (human) is an active analogue of the chemoattractant protein, angiotensin. It is a potent anti-inflammatory cytokine that inhibits the production of pro-inflammatory cytokines, such as IL-10. Angiotensin IV (human) has been shown to significantly reduce the production of pro-inflammatory cytokines in mice with chronic inflammation and can be used to treat autoimmune diseases. The biological properties of this protein have been studied using polymerase chain reactions and cytosolic calcium assays. It has been shown to inhibit binding to both the angiotensin receptor and angiotensin converting enzyme. Angiotensin IV (human) also has locomotor activity.Formula:C40H54N8O8Purity:Min. 95%Molecular weight:774.91 g/molRHOX11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RHOX11 antibody, catalog no. 70R-8214Purity:Min. 95%GLT8D2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GLT8D2 antibody, catalog no. 70R-7444Purity:Min. 95%H-TPARKHTS-OH
Peptide H-TPARKHTS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TPARKHTS-OH include the following: Studies on the B-cell epitopes of L-asparaginase W Jing , W Wutong, W Deyu, J Duxiao - Pharmaceutical , 2002 - europepmc.orghttps://europepmc.org/article/cba/376377 Probing the antigenicity of E. coli l-asparaginase by mutational analysis C Jianhua, W Yujun , J Ruibo, W Min, W Wutong - Molecular biotechnology, 2006 - Springerhttps://link.springer.com/article/10.1385/MB:33:1:57MON1A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MON1A antibody, catalog no. 70R-10081Purity:Min. 95%AF488 DBCO
CAS:Please enquire for more information about AF488 DBCO including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C39H28N4O11S2Purity:Min. 95%Color and Shape:PowderMolecular weight:792.8 g/molACTA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACTA1 antibody, catalog no. 70R-10210Purity:Min. 95%DAP3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DAP3 antibody, catalog no. 70R-10345Purity:Min. 95%BTNL8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BTNL8 antibody, catalog no. 70R-8838Purity:Min. 95%Orexin B, human
CAS:Orexin B, human agonizes Orexin receptors (OX1 Ki=420 nM, OX2 Ki=36 nM), promotes feeding in rats, and is a neuropeptide.Formula:C123H212N44O35SPurity:98%Color and Shape:SolidMolecular weight:2899.34Cortistatin-14
CAS:Cortistatin-14, a neuropeptide structurally similar to growth inhibitor-14, is used to study sepsis-induced cognitive impairment.Formula:C81H114N20O18S2Purity:98.06%Color and Shape:SolidMolecular weight:1720.03MLXIPL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MLXIPL antibody, catalog no. 20R-1229Purity:Min. 95%Ac-CDGPTEIYKLTRKEAQE-OH
Peptide Ac-CDGPTEIYKLTRKEAQE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-CDGPTEIYKLTRKEAQE-OH include the following: Wnt ligands from the embryonic surface ectoderm regulate 'bimetallic strip'optic cup morphogenesis in mouse AC Carpenter, AN Smith, H Wagner - , 2015 - journals.biologists.comhttps://journals.biologists.com/dev/article-abstract/142/5/972/47238Histatin 5
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.H-TEIALSGK^-OH
Peptide H-TEIALSGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TEIALSGK^-OH include the following: Arthur Viode1, Clemence Fournier2, 3, Agnacašs Camuzat2, 4, Franaca§ois Fenaille1, NeuroCEB Brain Bank, Morwena Latouche2, 4, Fanny Elahi5, Isabelle Le Ber2, 3, 6 LP Sugrue - Genetics of Neurodegenerative Diseases, 2021 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=O8JSEAAAQBAJ&oi=fnd&pg=PA75&dq=(%22TEIALSGK%22+OR+%22H-TEIALSGK%5E-OH%22+OR+%22H-TEIALSGK-OH%22+OR+%22TEIALSGK%5E%22)+AND+peptide&ots=ZjyONTXHv8&sig=1uHMdtVgBbs2rxSax15B0NswEo0 New antibody-free mass spectrometry-based quantification reveals that C9ORF72 long protein isoform is reduced in the frontal cortex of hexanucleotide-repeat A Viode, C Fournier, A Camuzat, F Fenaille - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnins.2018.00589/fullH-RLL^GTEFQV-OH
Peptide H-RLL^GTEFQV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLL^GTEFQV-OH include the following: MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas LE Stopfer , NJ Rettko, O Leddy - Proceedings of the , 2022 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2208900119 Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants LE Stopfer , AS Gajadhar, B Patel - Proceedings of the , 2021 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2111173118 SLC45A2: a melanoma antigen with high tumor selectivity and reduced potential for autoimmune toxicity J Park, AH Talukder, SA Lim, K Kim, K Pan - Cancer immunology , 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/8/618/468798Ac-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
Peptide Ac-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 include the following: Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii W Shang, X Yang, X Ju, Y Xie, Y Zhang - Journal of Peptide , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3017H-Myr-GSNK^SK^PK-NH2
Peptide H-Myr-GSNK^SK^PK-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-Myr-GSNK^SK^PK-NH2 include the following: Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancer OA Alsaidan , E Onobun , C Ye, L Lou , Z Beharry - The ..., 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pros.24645 Extracellular vesicles: The next generation of biomarkers and treatment for central nervous system diseases G Zanirati, PG Dos Santos, AM Alcará, F Bruzzo- International Journal of ..., 2024 - mdpi.comhttps://www.mdpi.com/1422-0067/25/13/7371 Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing JA Whitley , H Cai - Journal of Extracellular Vesicles, 2023 - Wiley Online Libraryhttps://isevjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jev2.12343 Encapsulating Cas9 into extracellular vesicles by protein myristoylation JA Whitley , S Kim, L Lou , C Ye- Journal of ..., 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jev2.12196 BFSP1 C-terminal domains released by post-translational processing events can alter significantly the calcium regulation of AQP0 water permeability A Tapodi , DM Clemens , A Uwineza , M Jarrin- Experimental eye ..., 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014483518307395H-RLRPGGKKKY-OH
Peptide H-RLRPGGKKKY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLRPGGKKKY-OH include the following: Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses RA Koup, M Roederer , L Lamoreaux, J Fischer - PloS one, 2010 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009015 Widespread impact of HLA restriction on immune control and escape pathways of HIV-1 JM Carlson , J Listgarten , N Pfeifer , V Tan - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.06728-11 Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A* 30-B* 13-C* 06-positive patients H Zhang, X Han, B Zhao, M An, Z Wang, F Jiang, J Xu - Aids, 2015 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2015/06010/multilayered_hiv_1_gag_specific_t_cell_responses.4.aspxBis-dPEG®7-Acid
CAS:Bis-dPEG®7-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®7-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.Formula:C22H39NO12Purity:Min. 95%Molecular weight:509.54 g/molPPP2R3A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPP2R3A antibody, catalog no. 70R-2338For-Nle-Leu-Phe-OH
CAS:Nle-Leu-Phe-OH is a potent colony-stimulating factor that binds to the receptor on the surface of cells and stimulates the production of white blood cells. Nle-Leu-Phe-OH has been shown to induce actin filament formation, which is necessary for cell movement. It also induces cytosolic calcium release and enhances protein synthesis. Nle-Leu-Phe-OH also binds to phosphatase and inhibits its activity, which may be due to a conformational change in the enzyme. This process is necessary for the synthesis of DNA and other proteins from amino acids. Nle-Leu-Phe-OH also causes an increase in the uptake of Ca2+ ions by cells.Formula:C22H33N3O5Purity:Min. 95%Molecular weight:419.51 g/molBim BH3, Peptide IV
CAS:This Bim peptide belongs to the pro-apoptotic group of the Bcl-2 family of proteins.Formula:C145H222N44O41SPurity:98%Color and Shape:SolidMolecular weight:3269.65VPS28 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VPS28 antibody, catalog no. 70R-2489Purity:Min. 95%B3GAT3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of B3GAT3 antibody, catalog no. 70R-6768Purity:Min. 95%TLQP-62, Rat
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:7,401.13 g/molMyr-RIIDLLWRVRRPQKPKFVTVWVR-OH
Peptide Myr-RIIDLLWRVRRPQKPKFVTVWVR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Myr-RIIDLLWRVRRPQKPKFVTVWVR-OH include the following: Broad-spectrum hybrid antimicrobial peptides derived from PMAP-23 with potential LPS binding ability Y Lyu, M Tan, M Xue, W Hou, C Yang, A Shan - Biochemical , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295223000916 Possible role of a PXXP central hinge in the antibacterial activity and membrane interaction of PMAP-23, a member of cathelicidin family ST Yang, JH Jeon, Y Kim , SY Shin, KS Hahm - Biochemistry, 2006 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi051524k Lipid-soluble hydroquinone modifications induced on membranes SS Funari, V Rebbin, L Marzorati, C Di Vitta - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05111-8.pdf Porcine myeloid antimicrobial peptides: a review of the activity and latest advances S Shi, T Shen, Y Liu, L Chen, C Wang - Frontiers in Veterinary , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fvets.2021.664139/full Probing the role of Proline in the antimicrobial activity and lipopolysaccharide binding of indolicidin S Bera , A Ghosh , S Sharma, T Debnath, B Giri - Journal of colloid and , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021979715004014 C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria JY Kim, SC Park, MY Yoon, KS Hahm, Y Park - Amino acids, 2011 - Springerhttps://link.springer.com/article/10.1007/s00726-010-0632-1 Inclusion of menaquinone in lipid membranes decreases susceptibility to antimicrobial peptides J Nepper - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05107-6.pdf Lipid Bilayers of Ester-Modified Lipids DY Villanueva, JB Lim , JB Klauda - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05110-6.pdf Regulation of Antimicrobial Peptide Activity through Lipid Chain Order DA Ramirez , DE Otzen, C Leidy - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05109-X.pdf In Vivo 2H-NMR Study of the Action of Antibacterial Agents on Escherichia Coli Membranes C Tardy-Laporte, AA Arnold, I Marcotte - Biophysical Journal, 2011 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(10)05108-8.pdfPILRB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PILRB antibody, catalog no. 70R-7227Purity:Min. 95%RFTN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RFTN2 antibody, catalog no. 70R-4543Purity:Min. 95%